GF Fund Management’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$31.8K Buy
617
+48
+8% +$2.44K ﹤0.01% 449
2026
Q2
$20.6K Sell
569
-28
-5% -$821 ﹤0.01% 479
2026
Q1
$14.7K Buy
597
+70
+13% +$1.22K ﹤0.01% 526
2025
Q4
$8.91K Buy
+527
New +$9.27K ﹤0.01% 583

Other funds holding ETON

GF Fund Management's ETON Position: Q3 2026 in Review

GF Fund Management increased its Eton Pharmaceutcials (ETON) stake by 8.4% in Q3 2026, buying an estimated $2.44K and bringing the position to 617 shares worth $31.8K. The position accounts for ﹤0.01% of the portfolio, ranked #449.

GF Fund Management first reported a position in ETON in Q4 2025 and has held it in 4 quarters since. 214 funds tracked by Wall St. Rank hold ETON as of Q3 2026.

  • GF Fund Management held 617 shares of Eton Pharmaceutcials worth $31.8K as of Q3 2026.
  • GF Fund Management bought 48 Eton Pharmaceutcials shares in Q3 2026, an estimated $2.44K.
  • Eton Pharmaceutcials made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #449 holding.
  • GF Fund Management first reported a position in Eton Pharmaceutcials in Q4 2025 and has held it in 4 quarters since.
  • 214 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q3 2026.

Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.